RCKT · Rocket Pharmaceuticals Inc. Common Stock
View on chartInsiders & Stakes
| RTW INVESTMENTS, LP 10% Owner | ▼ Sell | Other | 18,188,457 Shares held | 9/19/2025 | View profile |
| Gaurav Shah CEO | ▼ Sell | Open Market | 1,056,594 Shares held | 8/18/2026 | View profile |
| Martin Wilson General Counsel | ▼ Sell | Open Market | 598,489 Shares held | 9/11/2026 | View profile |
| Christopher James Stevens Chief Operating Officer | ▼ Sell | Open Market | 505,784 Shares held | 8/11/2026 | View profile |
| Patel Kinnari See Remarks | ▼ Sell | Open Market | 441,927 Shares held | 5/20/2025 | View profile |
| Makker Gotham | ▲ Buy | Grant | 415,346 Shares held | 6/18/2025 | View profile |
| Syed Ali-aamir Rizvi Chief Medical Officer | ▲ Buy | Grant | 407,874 Shares held | 2/11/2026 | View profile |
| Jonathan David Schwartz See Remarks | ▼ Sell | Open Market | 299,064 Shares held | 11/18/2025 | View profile |
| Sarbani Chaudhuri See Remarks | ▼ Sell | Open Market | 262,809 Shares held | 8/11/2026 | View profile |
| David P. Southwell Chief Executive Officer | ▼ Sell | Other | 204,522 Shares held | 8/3/2026 | View profile |
| Ondrey Aaron Chief Financial Officer | ▼ Sell | Open Market | 128,173 Shares held | 7/3/2025 | View profile |
| John Militello See Remarks | ▼ Sell | Open Market | 89,780 Shares held | 5/19/2026 | View profile |
| Peter Fong | ▲ Buy | Grant | 76,195 Shares held | 6/18/2026 | View profile |
| Roderick Wong Chief Executive Officer | ▲ Buy | Grant | 75,499 Shares held | 6/18/2026 | View profile |
| White Mark Andrew Chief Medical Officer | ▼ Sell | Open Market | 69,140 Shares held | 10/31/2024 | View profile |
| Mikael Dolsten Director | ▲ Buy | Grant | 67,082 Shares held | 6/18/2026 | View profile |
| GRANADILLO PEDRO P | ▲ Buy | Grant | 54,734 Shares held | 6/18/2025 | View profile |
| Fady Ibraham Malik EVP Research & Development | ▲ Buy | Grant | 52,862 Shares held | 6/18/2026 | View profile |
| Carsten Boess | ▲ Buy | Grant | 52,862 Shares held | 6/18/2026 | View profile |
| Elisabeth Bjork | ▲ Buy | Open Market | 50,000 Shares held | 1/2/2026 | View profile |
| Pratumsuwan Piratip | ▲ Buy | Grant | 30,000 Shares held | 6/18/2025 | View profile |
Transaction History
| Martin Wilson | ▼ Sell | Open Market | 75,364 | $256K | 9/11/2026 |
| Martin Wilson | ▼ Sell | Open Market | 631 | $2K | 8/18/2026 |
| Gaurav Shah | ▼ Sell | Open Market | 2,293 | $8K | 8/18/2026 |
| Gaurav Shah | ▼ Sell | Open Market | 2,837 | $10K | 8/13/2026 |
| Martin Wilson | ▼ Sell | Open Market | 3,493 | $12K | 8/13/2026 |
| Christopher James Stevens | ▼ Sell | Open Market | 36,658 | $128K | 8/11/2026 |
| Sarbani Chaudhuri | ▼ Sell | Open Market | 4,701 | $16K | 8/11/2026 |
| Christopher James Stevens | ▲ Buy | Grant | 73,313 | $0 | 8/3/2026 |
| David P. Southwell | ▼ Sell | Other | 150,000 | $0 | 8/3/2026 |
| Fady Ibraham Malik | ▲ Buy | Grant | 22,862 | $0 | 6/18/2026 |
| David P. Southwell | ▲ Buy | Grant | 22,862 | $0 | 6/18/2026 |
| Carsten Boess | ▲ Buy | Grant | 22,862 | $0 | 6/18/2026 |
| Roderick Wong | ▲ Buy | Grant | 27,832 | $0 | 6/18/2026 |
| Peter Fong | ▲ Buy | Grant | 22,862 | $0 | 6/18/2026 |
| Mikael Dolsten | ▲ Buy | Grant | 22,862 | $0 | 6/18/2026 |
| Gaurav Shah | ▲ Buy | Option Exercise | 76,490 | $129K | 5/21/2026 |
| Gaurav Shah | ▼ Sell | Open Market | 55,684 | $172K | 5/21/2026 |
| Martin Wilson | ▼ Sell | Open Market | 662 | $2K | 5/19/2026 |
| John Militello | ▼ Sell | Open Market | 384 | $1K | 5/19/2026 |
| Gaurav Shah | ▼ Sell | Open Market | 2,409 | $7K | 5/19/2026 |
| Martin Wilson | ▼ Sell | Open Market | 3,361 | $12K | 5/13/2026 |
| Gaurav Shah | ▼ Sell | Open Market | 2,728 | $10K | 5/13/2026 |
| John Militello | ▼ Sell | Open Market | 855 | $3K | 5/13/2026 |
| Sarbani Chaudhuri | ▼ Sell | Open Market | 17,650 | $68K | 5/7/2026 |
| John Militello | ▼ Sell | Open Market | 1,157 | $4K | 2/18/2026 |
| Gaurav Shah | ▼ Sell | Open Market | 5,990 | $20K | 2/18/2026 |
| Martin Wilson | ▼ Sell | Open Market | 1,376 | $5K | 2/18/2026 |
| Martin Wilson | ▼ Sell | Open Market | 12,253 | $41K | 2/13/2026 |
| John Militello | ▼ Sell | Open Market | 3,726 | $12K | 2/13/2026 |
| Gaurav Shah | ▼ Sell | Open Market | 12,279 | $41K | 2/13/2026 |
| Gaurav Shah | ▲ Buy | Grant | 286,028 | $0 | 2/11/2026 |
| Christopher James Stevens | ▲ Buy | Grant | 61,963 | $0 | 2/11/2026 |
| Sarbani Chaudhuri | ▲ Buy | Grant | 125,924 | $0 | 2/11/2026 |
| John Militello | ▲ Buy | Grant | 29,982 | $0 | 2/11/2026 |
| Martin Wilson | ▲ Buy | Grant | 311,813 | $0 | 2/11/2026 |
| Syed Ali-aamir Rizvi | ▲ Buy | Grant | 61,963 | $0 | 2/11/2026 |
| Elisabeth Bjork | ▲ Buy | Open Market | 10,000 | $34K | 1/2/2026 |
| Jonathan David Schwartz | ▼ Sell | Open Market | 2,545 | $8K | 11/18/2025 |
| John Militello | ▼ Sell | Open Market | 1,086 | $3K | 11/18/2025 |
| Gaurav Shah | ▼ Sell | Open Market | 6,276 | $19K | 11/18/2025 |
| Martin Wilson | ▼ Sell | Open Market | 1,646 | $5K | 11/18/2025 |
| Martin Wilson | ▲ Buy | Grant | 100,000 | $0 | 11/3/2025 |
| John Militello | ▼ Sell | Open Market | 19,841 | $79K | 10/14/2025 |
| John Militello | ▼ Sell | Open Market | 5,514 | $22K | 10/14/2025 |
| John Militello | ▼ Sell | Open Market | 3,005 | $12K | 10/14/2025 |
| John Militello | ▼ Sell | Open Market | 558 | $2K | 10/14/2025 |
| Syed Ali-aamir Rizvi | ▲ Buy | Grant | 283,018 | $0 | 10/6/2025 |
| Syed Ali-aamir Rizvi | ▲ Buy | Grant | 62,893 | $0 | 10/6/2025 |
| Peter Fong | ▲ Buy | Grant | 30,000 | $0 | 9/24/2025 |
| Peter Fong | ▲ Buy | Grant | 23,333 | $0 | 9/24/2025 |
| RTW INVESTMENTS, LP | ▼ Sell | Other | 59,000 | $183K | 9/19/2025 |
| RTW INVESTMENTS, LP | ▼ Sell | Other | 41,000 | $127K | 9/19/2025 |
| RTW INVESTMENTS, LP | ▼ Sell | Other | 59,000 | $1.1M | 9/19/2025 |
| RTW INVESTMENTS, LP | ▼ Sell | Other | 1,000,000 | $40.0M | 9/19/2025 |
| RTW INVESTMENTS, LP | ▼ Sell | Other | 1,000,000 | $3.1M | 9/19/2025 |
| RTW INVESTMENTS, LP | ▼ Sell | Other | 41,000 | $783K | 9/19/2025 |
| Jonathan David Schwartz | ▲ Buy | Grant | 80,000 | $0 | 9/8/2025 |
| John Militello | ▲ Buy | Grant | 40,000 | $0 | 9/8/2025 |
| Martin Wilson | ▲ Buy | Grant | 150,000 | $0 | 9/8/2025 |
| Elisabeth Bjork | ▲ Buy | Open Market | 10,000 | $34K | 8/27/2025 |
| John Militello | ▼ Sell | Open Market | 361 | $1K | 8/19/2025 |
| Jonathan David Schwartz | ▼ Sell | Open Market | 805 | $2K | 8/19/2025 |
| Martin Wilson | ▼ Sell | Open Market | 588 | $2K | 8/19/2025 |
| John Militello | ▼ Sell | Open Market | 699 | $2K | 8/18/2025 |
| Jonathan David Schwartz | ▼ Sell | Open Market | 1,680 | $5K | 8/18/2025 |
| Martin Wilson | ▼ Sell | Open Market | 1,004 | $3K | 8/18/2025 |
| Gaurav Shah | ▼ Sell | Tax Withholding | 2,234 | $7K | 8/18/2025 |
| Jonathan David Schwartz | ▼ Sell | Open Market | 11,161 | $34K | 8/14/2025 |
| John Militello | ▼ Sell | Open Market | 7,043 | $21K | 8/14/2025 |
| Martin Wilson | ▼ Sell | Open Market | 12,109 | $37K | 8/14/2025 |
| Christopher James Stevens | ▲ Buy | Grant | 407,166 | $0 | 8/4/2025 |
| Ondrey Aaron | ▼ Sell | Open Market | 1,477 | $4K | 7/3/2025 |
| Mikael Dolsten | ▲ Buy | Grant | 30,000 | $0 | 6/18/2025 |
| GRANADILLO PEDRO P | ▲ Buy | Grant | 30,000 | $0 | 6/18/2025 |
| GRANADILLO PEDRO P | ▲ Buy | Grant | 24,734 | $0 | 6/18/2025 |
| Roderick Wong | ▲ Buy | Grant | 30,000 | $0 | 6/18/2025 |
| Roderick Wong | ▲ Buy | Grant | 17,667 | $0 | 6/18/2025 |
| Makker Gotham | ▲ Buy | Grant | 30,000 | $0 | 6/18/2025 |
| Makker Gotham | ▲ Buy | Grant | 19,434 | $0 | 6/18/2025 |
| Fady Ibraham Malik | ▲ Buy | Grant | 30,000 | $0 | 6/18/2025 |
| Carsten Boess | ▲ Buy | Grant | 30,000 | $0 | 6/18/2025 |
| Elisabeth Bjork | ▲ Buy | Grant | 30,000 | $0 | 6/18/2025 |
| Pratumsuwan Piratip | ▲ Buy | Grant | 30,000 | $0 | 6/18/2025 |
| David P. Southwell | ▲ Buy | Grant | 30,000 | $0 | 6/18/2025 |
| John Militello | ▼ Sell | Open Market | 357 | $2K | 5/20/2025 |
| Jonathan David Schwartz | ▼ Sell | Open Market | 801 | $5K | 5/20/2025 |
| Patel Kinnari | ▼ Sell | Open Market | 767 | $5K | 5/20/2025 |
| Gaurav Shah | ▼ Sell | Open Market | 2,253 | $15K | 5/20/2025 |
| Martin Wilson | ▼ Sell | Open Market | 587 | $4K | 5/20/2025 |
| Jonathan David Schwartz | ▼ Sell | Open Market | 1,582 | $10K | 5/16/2025 |
| Gaurav Shah | ▼ Sell | Open Market | 3,621 | $24K | 5/16/2025 |
| Martin Wilson | ▼ Sell | Open Market | 946 | $6K | 5/16/2025 |
| John Militello | ▼ Sell | Open Market | 655 | $4K | 5/16/2025 |
| Patel Kinnari | ▼ Sell | Open Market | 1,409 | $9K | 5/16/2025 |
| John Militello | ▼ Sell | Open Market | 718 | $5K | 4/22/2025 |
| Gaurav Shah | ▲ Buy | Open Market | 20,000 | $102K | 4/10/2025 |
| Patel Kinnari | ▲ Buy | Open Market | 21,099 | $99K | 4/9/2025 |
| Ondrey Aaron | ▼ Sell | Open Market | 7,489 | $40K | 4/4/2025 |
| Mikael Dolsten | ▼ Sell | Other | 14,220 | $0 | 3/5/2025 |
| Jonathan David Schwartz | ▼ Sell | Open Market | 6,532 | $69K | 2/25/2025 |
| Patel Kinnari | ▼ Sell | Open Market | 6,078 | $64K | 2/21/2025 |
| Martin Wilson | ▼ Sell | Open Market | 3,222 | $34K | 2/21/2025 |
| Gaurav Shah | ▼ Sell | Open Market | 16,303 | $172K | 2/21/2025 |
| John Militello | ▼ Sell | Open Market | 2,737 | $29K | 2/21/2025 |
| Ondrey Aaron | ▲ Buy | Grant | 90,358 | $0 | 2/11/2025 |
| John Militello | ▲ Buy | Grant | 20,080 | $0 | 2/11/2025 |
| Patel Kinnari | ▲ Buy | Grant | 57,786 | $0 | 2/11/2025 |
| Jonathan David Schwartz | ▲ Buy | Grant | 80,318 | $0 | 2/11/2025 |
| Martin Wilson | ▲ Buy | Grant | 90,358 | $0 | 2/11/2025 |
| Gaurav Shah | ▲ Buy | Grant | 81,655 | $0 | 2/11/2025 |
| John Militello | ▼ Sell | Open Market | 896 | $9K | 1/23/2025 |
| Jonathan David Schwartz | ▼ Sell | Open Market | 3,097 | $40K | 11/21/2024 |
| John Militello | ▼ Sell | Open Market | 1,224 | $16K | 11/21/2024 |
| Patel Kinnari | ▼ Sell | Open Market | 4,588 | $60K | 11/21/2024 |
| Martin Wilson | ▼ Sell | Open Market | 1,175 | $15K | 11/21/2024 |
| Gaurav Shah | ▼ Sell | Open Market | 11,091 | $145K | 11/21/2024 |
| John Militello | ▼ Sell | Open Market | 917 | $15K | 10/31/2024 |
| White Mark Andrew | ▼ Sell | Open Market | 3,080 | $51K | 10/31/2024 |
| Jonathan David Schwartz | ▼ Sell | Open Market | 2,710 | $50K | 8/16/2024 |
| John Militello | ▼ Sell | Open Market | 1,064 | $20K | 8/16/2024 |
| Patel Kinnari | ▼ Sell | Open Market | 3,989 | $74K | 8/16/2024 |
| Martin Wilson | ▼ Sell | Open Market | 1,027 | $19K | 8/16/2024 |
| Gaurav Shah | ▼ Sell | Open Market | 9,650 | $179K | 8/16/2024 |
| John Militello | ▼ Sell | Open Market | 812 | $19K | 7/22/2024 |
| White Mark Andrew | ▼ Sell | Open Market | 3,026 | $62K | 7/8/2024 |
| Jonathan David Schwartz | ▼ Sell | Open Market | 2,754 | $64K | 5/17/2024 |
| Patel Kinnari | ▼ Sell | Open Market | 4,046 | $94K | 5/16/2024 |
| John Militello | ▼ Sell | Open Market | 1,079 | $25K | 5/16/2024 |
| Gaurav Shah | ▼ Sell | Open Market | 9,790 | $229K | 5/16/2024 |
| Martin Wilson | ▼ Sell | Open Market | 1,048 | $24K | 5/16/2024 |
| Gaurav Shah | ▲ Buy | Option Exercise | 7,979 | $0 | 5/14/2024 |
| Gaurav Shah | ▲ Buy | Option Exercise | 9,683 | $0 | 5/14/2024 |
| Martin Wilson | ▲ Buy | Option Exercise | 2,420 | $0 | 5/14/2024 |
| Patel Kinnari | ▲ Buy | Option Exercise | 3,990 | $0 | 5/14/2024 |
| Patel Kinnari | ▲ Buy | Option Exercise | 5,553 | $0 | 5/14/2024 |
| David P. Southwell | ▼ Sell | Gift | 59,716 | $0 | 5/2/2024 |
| David P. Southwell | ▼ Sell | Gift | 113,124 | $0 | 5/2/2024 |
| John Militello | ▼ Sell | Open Market | 833 | $19K | 4/22/2024 |
| David P. Southwell | ▲ Buy | Option Exercise | 29,624 | $129K | 4/15/2024 |
| David P. Southwell | ▼ Sell | Open Market | 10,000 | $241K | 4/15/2024 |
| David P. Southwell | ▲ Buy | Option Exercise | 70,000 | $304K | 4/12/2024 |
| David P. Southwell | ▼ Sell | Open Market | 59,716 | $1.4M | 4/12/2024 |
| David P. Southwell | ▼ Sell | Open Market | 10,284 | $259K | 4/12/2024 |
| White Mark Andrew | ▼ Sell | Open Market | 12,532 | $309K | 4/8/2024 |
| Ondrey Aaron | ▲ Buy | Grant | 46,781 | $0 | 4/1/2024 |
| Makker Gotham | ▼ Sell | Open Market | 274,000 | $7.8M | 3/21/2024 |
| John Militello | ▼ Sell | Open Market | 2,490 | $70K | 3/21/2024 |
| John Militello | ▲ Buy | Option Exercise | 10,000 | $126K | 2/29/2024 |
| John Militello | ▼ Sell | Open Market | 10,000 | $298K | 2/29/2024 |
| Martin Wilson | ▼ Sell | Open Market | 4,100 | $120K | 2/29/2024 |
| Martin Wilson | ▼ Sell | Open Market | 3,576 | $107K | 2/16/2024 |
| Patel Kinnari | ▼ Sell | Open Market | 7,132 | $213K | 2/16/2024 |
| John Militello | ▼ Sell | Open Market | 3,238 | $97K | 2/16/2024 |
| Patel Kinnari | ▲ Buy | Grant | 33,288 | $0 | 2/16/2024 |
| Martin Wilson | ▲ Buy | Grant | 16,644 | $0 | 2/16/2024 |
| John Militello | ▲ Buy | Grant | 8,322 | $0 | 2/16/2024 |
| White Mark Andrew | ▲ Buy | Grant | 11,096 | $0 | 2/16/2024 |
| Gaurav Shah | ▼ Sell | Open Market | 20,272 | $605K | 2/16/2024 |
| Gaurav Shah | ▲ Buy | Grant | 66,577 | $0 | 2/16/2024 |
| Gaurav Shah | ▲ Buy | Option Exercise | 46,828 | $0 | 2/14/2024 |
| Patel Kinnari | ▲ Buy | Option Exercise | 26,189 | $0 | 2/14/2024 |
| John Militello | ▲ Buy | Option Exercise | 6,274 | $0 | 2/14/2024 |
| Martin Wilson | ▲ Buy | Option Exercise | 9,712 | $0 | 2/14/2024 |
| John Militello | ▼ Sell | Open Market | 638 | $17K | 1/22/2024 |
| John Militello | ▲ Buy | Option Exercise | 1,586 | $0 | 1/18/2024 |
| Makker Gotham | ▼ Sell | Open Market | 20,000 | $451K | 11/15/2023 |
| Patel Kinnari | ▲ Buy | Option Exercise | 3,989 | $0 | 11/14/2023 |
| John Militello | ▲ Buy | Option Exercise | 725 | $0 | 11/14/2023 |
| Gaurav Shah | ▲ Buy | Option Exercise | 7,979 | $0 | 11/14/2023 |
| John Militello | ▼ Sell | Open Market | 564 | $10K | 10/20/2023 |
| Patel Kinnari | ▲ Buy | Option Exercise | 3,333 | $0 | 10/5/2023 |
| Makker Gotham | ▼ Sell | Open Market | 4,677 | $99K | 9/29/2023 |
| Makker Gotham | ▼ Sell | Open Market | 10,312 | $217K | 9/28/2023 |
| RTW INVESTMENTS, LP | ▼ Sell | Other | 500,000 | $11.0M | 8/28/2023 |
| RTW INVESTMENTS, LP | ▼ Sell | Other | 500,000 | $7.9M | 8/28/2023 |
| RTW INVESTMENTS, LP | ▼ Sell | Other | 500,000 | $7.9M | 8/28/2023 |
| RTW INVESTMENTS, LP | ▼ Sell | Other | 500,000 | $11.0M | 8/28/2023 |
| Patel Kinnari | ▼ Sell | Open Market | 1,534 | $24K | 8/17/2023 |
| Gaurav Shah | ▼ Sell | Open Market | 4,767 | $74K | 8/17/2023 |
| John Militello | ▼ Sell | Open Market | 284 | $4K | 8/17/2023 |
| John Militello | ▲ Buy | Option Exercise | 725 | $0 | 8/14/2023 |
| Patel Kinnari | ▲ Buy | Option Exercise | 3,989 | $0 | 8/14/2023 |
| Gaurav Shah | ▲ Buy | Option Exercise | 7,979 | $0 | 8/14/2023 |
| John Militello | ▼ Sell | Open Market | 573 | $11K | 7/20/2023 |
| John Militello | ▲ Buy | Option Exercise | 1,586 | $0 | 7/18/2023 |
| Gaurav Shah | ▼ Sell | Open Market | 4,122 | $88K | 5/17/2023 |
| Patel Kinnari | ▼ Sell | Open Market | 1,330 | $28K | 5/17/2023 |
| John Militello | ▼ Sell | Open Market | 245 | $5K | 5/17/2023 |
| Gaurav Shah | ▲ Buy | Option Exercise | 7,979 | $0 | 5/14/2023 |
| John Militello | ▲ Buy | Option Exercise | 725 | $0 | 5/14/2023 |
| Patel Kinnari | ▲ Buy | Option Exercise | 3,989 | $0 | 5/14/2023 |
| John Militello | ▼ Sell | Open Market | 2,342 | $44K | 4/21/2023 |
| John Militello | ▲ Buy | Option Exercise | 6,364 | $0 | 4/18/2023 |
| White Mark Andrew | ▲ Buy | Grant | 76,662 | $0 | 4/4/2023 |
| Jonathan David Schwartz | ▼ Sell | Open Market | 3,557 | $68K | 2/17/2023 |
| Gaurav Shah | ▼ Sell | Open Market | 12,194 | $232K | 2/17/2023 |
| John Militello | ▼ Sell | Open Market | 1,244 | $24K | 2/17/2023 |
| John Militello | ▼ Sell | Other | 11,067 | $0 | 2/14/2023 |
| Patel Kinnari | ▼ Sell | Other | 38,735 | $0 | 2/14/2023 |
| Martin Wilson | ▼ Sell | Other | 16,947 | $0 | 2/14/2023 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Rocket Pharmaceuticals Gets FDA Alignment on Heart Drug Trial
Rocket Pharmaceuticals has secured FDA alignment on a trial for its heart drug, which may help address prior safety concerns. This regulatory step is significant for the company's development timeline. The stock is currently trading near its 52-week low, reflecting ongoing market caution despite this progress.
Rocket Pharmaceuticals Gets FDA Alignment on Heart Drug Trial. Rocket Pharmaceuticals has secured FDA alignment on a trial for its heart drug, which may help address prior safety concerns. This regulatory step is significant for the company's development timeline. The stock is currently trading near its 52-week low, reflecting ongoing market caution despite this progress.